Utah People's Post

The Latest News from the Beehive State

Saturday, July 2, 2022
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / FDA Approves $11,000 Cheaper Hepatitis C Drug

FDA Approves $11,000 Cheaper Hepatitis C Drug

December 20, 2014 Posted by Editor

FDA Approves $11,000 Cheaper Hepatitis C Drug

On Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie’s Viekira Pak, a new hepatitis C cure, that will challenge Gilead Sciences’ more expensive cure. Both FDA and Medicaid programs hoped that the new drug would bring some real competition in hepatitis C drug market.

However, there wasn’t much improvement, since AbbVie is going to sell a 12-week kit of the new drug for $83,319. Although it is about $11,000 cheaper than Gilead’s Harvoni, Viekira Pak is still pricey.

David Lassen, a Prime Therapeutics’ spokesperson, said that the wholesale price was higher than expected. But Morry Smulevitz, Abb Vie representative, said that the price reflected both “market dynamics” and the “value it brought to the health care system.” Additionally, some patients may need only an 8-week therapy for full recovery, thus lowering the price.

Viekira Pak is a mix of four drugs that eradicates hepatitis C Genotype 1 virus, the most common type of virus, as efficiently as Harvoni. The rate at which it cures the patients is 90 percent.

However, AbbVie’s cheaper hepatitis C drug has a major drawback – patients would have to take 6 pills a day, instead of two as they did with Harvoni. Viekira Pak therapy involves three tablets to be taken in the morning, one in the evening and an additional drug, ribavirin, which consists in two more pills. Ribavirin is not mandatory, but it is highly recommended during the cure.

Some pharmacists believe that taking so many pills would confuse patients and prevent them from getting their medication, while others say that the time span of the cure (12 weeks) is so short that there isn’t such danger.

About 3 million Americans have hepatitis C nowadays. If not treated, the disease can lead to liver cirrhosis followed by liver cancer.

AbbVie has another blockbusting drug, Humira, that recoded sales for nearly $10 billion in the first three trimesters of this year, surpassing Gilead’s Sovaldi, Harvoni’s predecessor, as the best selling drug in the world.

Some say that Viekira Pak is so expensive because AbbVie wants to make it its primary source of revenue after Humira’s patent would have expired in the U.S. in two years time. In 2016, Humira would lose monopoly because other drug makers could copy and sell it at much lower prices.

Drug experts say that even with a 20 percent of hepatitis C drug market share, AbbVie’s revenues could reach $2 billion a year just by selling Viekira Pak.

Image Source: everyday HEALTH

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health Tagged With: AbbVie pharma, best selling drug, cheaper hepatitis C drug, Gilead Sciences pharma, Harvoni drug, hepatitis C cure, Humira, ribavirin, Sovaldi drug, U.S. Food and Drug Administration (FDA), Viekira Pak

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

June 29, 2018 By Amelia Donovan

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

June 29, 2018 By Amelia Donovan

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

June 28, 2018 By Amelia Donovan

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

June 27, 2018 By Amelia Donovan

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

June 27, 2018 By Amelia Donovan

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

June 26, 2018 By Amelia Donovan

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

June 25, 2018 By Amelia Donovan

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

June 23, 2018 By Amelia Donovan

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

June 22, 2018 By Amelia Donovan

456 People Dead at U.K. Hospital after Taking too Many Painkillers

June 21, 2018 By Amelia Donovan

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

June 20, 2018 By Amelia Donovan

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

    Jun 29, 2018
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

    Jun 29, 2018
  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

    Jun 27, 2018
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

    Jun 25, 2018
  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

    Jun 22, 2018
  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

    Jun 21, 2018
  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

    Jun 19, 2018
  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

    Jun 18, 2018
  • Our Brains Are Craving Combinations of Fats and Carbs (Study)

    Jun 15, 2018
  • Hungry bird with beck open

    Scientists Explain Why We Get ‘Hangry’

    Jun 13, 2018

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2022 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact